Please login to the form below

Not currently logged in
Email:
Password:

Almirall appoints first woman to the board

Karin Louise Dorrepaal will serve as an independent board member

Spanish pharmaceutical company Almirall has picked Karin Louise Dorrepaal to sit on its board of directors as an independent board member.

She is the first woman to join the Barcelona-based company's ten member board and has gained extensive international experience in the pharmaceutical sector during her 25 year career.

This includes six years serving as director of global business unit diagnostic imaging and supply chain and procurement at Bayer Pharma and sitting on the board of Schering for two years.

Dorrepaal currently holds non-executive positions in healthcare sector and consultancy companies.

Earlier this month, she was appointed to the supervisory board of German specialty pharma company Paion, where she replaced Grünenthal chief executive Harald Stock. 

Dorrepaal's appointment to the Almirall board will take effect from January 1, 2013, and will be ratified at the company's next annual general meeting.

23rd November 2012

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics